Astrana Health Inc (ASTH)vsTenet Healthcare Corporation (THC)
ASTH
Astrana Health Inc
$37.99
+0.37%
HEALTHCARE · Cap: $1.87B
THC
Tenet Healthcare Corporation
$162.06
+0.43%
HEALTHCARE · Cap: $15.04B
Smart Verdict
WallStSmart Research — data-driven comparison
Tenet Healthcare Corporation generates 508% more annual revenue ($21.45B vs $3.53B). THC leads profitability with a 7.9% profit margin vs 0.9%. THC trades at a lower P/E of 9.1x. THC earns a higher WallStSmart Score of 66/100 (B-).
ASTH
Buy56
out of 100
Grade: C
THC
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.9%
Fair Value
$188.57
Current Price
$37.99
$150.58 discount
Intrinsic value data unavailable for THC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 55.6% year-over-year
Earnings expanding 110.1% YoY
Reasonable price relative to book value
Attractively priced relative to earnings
Every $100 of equity generates 35 in profit
Earnings expanding 87.6% YoY
Generating 1.5B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
ROE of 3.8% — below average capital efficiency
0.9% margin — thin
Operating margin of 3.0%
2.8% revenue growth
Distress zone — elevated risk
7.9% margin — thin
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 55.6% demonstrates continued momentum.
Bull Case : THC
The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Profit Margin. A P/E of 61.7x leaves little room for execution misses. Thin 0.9% margins leave little buffer for downturns.
Bear Case : THC
The primary concerns for THC are Revenue Growth, Altman Z-Score, Profit Margin. Debt-to-equity of 2.74 is elevated, increasing financial risk.
Key Dynamics to Monitor
ASTH profiles as a hypergrowth stock while THC is a value play — different risk/reward profiles.
THC carries more volatility with a beta of 1.28 — expect wider price swings.
ASTH is growing revenue faster at 55.6% — sustainability is the question.
THC generates stronger free cash flow (1.5B), providing more financial flexibility.
Bottom Line
THC scores higher overall (66/100 vs 56/100). ASTH offers better value entry with a 89.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Tenet Healthcare Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?